医药政策法规
- (2023-01-05)
- (2023-01-05)
曹云龙团队最新成果:XBB.1.5传播性增强由ACE2的强结合和抗体逃逸共同促成,中和抗体SA55对XBB.1.5仍有很强的活性
(2023-01-05)- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-05)
- (2023-01-04)
- (2023-01-04)
- (2023-01-04)
- (2023-01-04)
- (2023-01-04)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2023-01-03)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-31)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-30)
- (2022-12-29)
- (2022-12-29)
- (2022-12-29)
- (2022-12-29)
- (2022-12-29)
- (2022-12-29)
- (2022-12-29)
- (2022-12-29)